Olema Pharmaceuticals Inc... (OLMA)
5.36
0.22 (4.28%)
At close: Jan 15, 2025, 1:20 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -96.66M | -104.79M | -71.10M | -22.12M | -4.32M | -2.20M |
| Depreciation & Amortization | 377.00K | 357.00K | 163.00K | 11.00K | 9.00K | 8.00K |
| Stock-Based Compensation | 17.26M | 18.83M | 15.91M | 3.11M | n/a | 1K |
| Other Working Capital | -2.91M | 2.67M | 3.51M | -1.28M | 58.00K | -10.00K |
| Other Non-Cash Items | -4.12M | 514.00K | 1.22M | 641.00K | -1.15M | 122.00K |
| Deferred Income Tax | n/a | n/a | 276.00K | n/a | n/a | n/a |
| Change in Working Capital | -589.00K | 3.02M | 2.83M | -1.50M | 1.23M | -110.00K |
| Operating Cash Flow | -83.73M | -82.06M | -50.69M | -19.87M | -3.08M | -2.18M |
| Capital Expenditures | n/a | -363.00K | -1.57M | -56.00K | n/a | n/a |
| Acquisitions | n/a | 363.00K | 1.57M | n/a | n/a | n/a |
| Purchase of Investments | -255.63M | -213.66M | -486.97M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 250.76M | 305.50M | 213.10M | n/a | n/a | n/a |
| Other Investing Acitivies | 14.00K | -363.00K | -1.57M | -56.00K | n/a | n/a |
| Investing Cash Flow | -4.85M | 91.48M | -275.44M | -56.00K | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 3.09M | n/a | 323.00K |
| Common Stock Repurchased | n/a | n/a | n/a | -2.29M | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 3.68M | 476.00K | 1.39M | 134.76M | n/a | 9.86M |
| Financial Cash Flow | 133.41M | 476.00K | 1.39M | 358.40M | n/a | 5.25M |
| Net Cash Flow | 44.84M | 9.89M | -324.74M | 338.48M | -3.08M | 3.08M |
| Free Cash Flow | -83.73M | -82.43M | -52.27M | -19.92M | -3.08M | -2.18M |